Skip to content
OpenCapital
Get started

Neumora Therapeutics, Inc. NMRA Q4 2024 Annual earnings

Reported March 3, 2025 · Before market open

EPS-$0.37Beat by $0.09
EPS estimate-$0.46

Next report

Aug 5, 2026 (In 1 week)
EPS estimate-$0.23

Versus estimates

Diluted EPS

Q1 2026-$0.30Beat by $0.02Q4 2025-$0.35Miss by $0.01Q3 2025-$0.35Miss by $0.01Q2 2025-$0.33Beat by $0.05Q1 2025-$0.42Miss by $0.02
Q4 2024-$0.37Beat by $0.09

Ask the moment Neumora Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Neumora Therapeutics, Inc. report Q4 2024 earnings?
Neumora Therapeutics, Inc. (NMRA) reported Q4 2024 earnings on March 3, 2025 before market open.
What were Neumora Therapeutics, Inc.'s Q4 2024 revenue and EPS?
Neumora Therapeutics, Inc. reported eps of $-0.37 for Q4 2024.
Did Neumora Therapeutics, Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.46 by $0.09.
Where can I find Neumora Therapeutics, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-030401) directly on SEC EDGAR. The filing index links above go to sec.gov.